Cholesterol & Alzheimer´s disease
Evidence for the role of cholesterol in Alzheimer’s disease (AD) has been growing in recent years and many cardiovascular risk factors have also been associated. Apolipoprotein E, a cholesterol transporter, is the primary genetic variant associated with sporadic AD risk, supporting a central role for the cholesterol in the disease. Additionally, statins are beginning to show benefits in a wide range of neuropathological conditions. In AD, epidemiological studies have demonstrated that the intake of statins decreases the risk of suffering the disease, although the precise mechanism remains elusive.

This website has been set up for the purpose of being a forum for the scientist community for  the discussion about the role for the cholesterol in the AD.